Aldosterone contributes to elevated left ventricular mass in black boys

Diana G Murro1, Melinda Beavers, Gregory A Harshfield

  • 1Department of Medicine, Georgia Health Sciences University, MCG Annex H.S. 1640, Augusta, GA, 30912-4534, USA. dmurro@georgiahealth.edu

Insights

This study reveals that aldosterone influences blood pressure and left ventricular mass index (LVMI) differently across racial and sex groups in adolescents. In black males, higher aldosterone is linked to increased LVMI, suggesting a pathway to left ventricular hypertrophy (LVH).

Area of Science:

  • Cardiovascular Physiology
  • Endocrinology
  • Pediatric Cardiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular events in adults and children.
  • Studies in adults show a direct correlation between renin-angiotensin-aldosterone system (RAAS) levels and left ventricular mass index (LVMI).

Purpose of the Study:

  • To investigate the race- and sex-specific effects of the RAAS on LVMI in adolescents.
  • To explore potential differences in RAAS-mediated cardiovascular risk factors among adolescent racial and sex groups.

Main Methods:

  • A cross-sectional study involving 89 black and 102 white adolescents (aged 15-19).
  • Data collected included sex, age, body mass index (BMI), LVMI, blood pressure, and levels of aldosterone and angiotensin II.

Main Results:

  • In black males, elevated aldosterone correlated with decreased sodium excretion, increased blood pressure, and increased LVMI.
  • In black females, aldosterone correlated with increased blood pressure.
  • In white males, aldosterone correlated with decreased sodium excretion. In white females, aldosterone correlated with increased blood pressure and decreased sodium excretion.

Conclusions:

  • The findings suggest a model in black males where aldosterone increases sodium retention, leading to elevated blood pressure and subsequently increased left ventricular mass, potentially causing LVH.
  • Race and sex significantly modulate the relationship between aldosterone, blood pressure, and LVMI in adolescents.
Abstract

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...